3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Pain, Postoperative
5
Breast Neoplasms
3
Thyroid Neoplasms
2
Chronic Pain
2
Brain Neoplasms
2
Agnosia
2
Urinary Bladder Neoplasms
1
Thrombosis
1
Sleep Initiation and Maintenance Disorders
1
Sigmoid Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Pain
1
Opioid Consumption, Postoperative
1
Neuroinflammatory Diseases
1
Meningioma
1
Lung Injury
1
Inflammation
1
Hypoxia
1
Hyperthyroidism
1
Goiter
1
Elderly
1
Delirium
1
Colorectal Neoplasms
1
Breast Cancer Female
1
Abdominal Cancer Surgeries
1
Interventions
Magnetic Resonance Spectroscopy
7
lutetium Lu 177 dotatate
6
Specimen Handling
5
Bevacizumab
4
gallium Ga 68 dotatate
3
abemaciclib
3
Radiosurgery
3
Proton Therapy
3
Nivolumab
3
pembrolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Protons
2
Observation
2
ONC206
2
Ipilimumab
2
Hydroxyurea
2
Ga(III)-DOTATOC
2
Everolimus
2
Elasticity Imaging Techniques
2
CTLA-4 Antigen
2
ribociclib
1
regorafenib
1
olaparib
1
neratinib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
capivasertib
1
cabozantinib
1
brigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningioma
×
Dexmedetomidine
×
1 year
×
Clear all
NCT07398066
2026-02-09
DEX-NEURO
University of Malaya
Phase NA
Not yet recruiting
60 enrolled